Shoulder pain drug trial halted early
NCT ID NCT05722522
First seen Jan 04, 2026 · Last updated May 22, 2026 · Updated 26 times
Summary
This study tested whether secukinumab (a drug that targets inflammation) could reduce pain and improve shoulder function in adults with moderate to severe rotator cuff tendinopathy. Participants received either the drug or a placebo, plus standard care, for 24 weeks. The study was terminated early after enrolling only 33 people, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ROTATOR CUFF TENDINOPATHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Healthy Life Research
Miami, Florida, 33184, United States
-
IRIS Research and Development
Plantation, Florida, 33324, United States
-
Millennium Clinical Trials
Westlake Village, California, 91361, United States
-
Novartis Investigative Site
San Miguel Tucuman, Tucumán Province, 4000, Argentina
-
Novartis Investigative Site
Buenos Aires, C1114AAP, Argentina
-
Novartis Investigative Site
San Miguel de Tucumán, 4000, Argentina
-
Novartis Investigative Site
Sofia, 1336, Bulgaria
-
Novartis Investigative Site
Québec, Quebec, G1V 3M7, Canada
-
Novartis Investigative Site
Brno, Czech Republic, 66250, Czechia
-
Novartis Investigative Site
Kolín, 280 02, Czechia
-
Novartis Investigative Site
Kota Kinabalu, Sabah, 88300, Malaysia
-
Novartis Investigative Site
Ponte de Lima, 4990-041, Portugal
-
Precision Clinical Research LLC
Sunrise, Florida, 33351, United States
-
West Clinical Research
Morehead City, North Carolina, 28557, United States
-
West Tennessee Research Institute
Jackson, Tennessee, 38305, United States
Conditions
Explore the condition pages connected to this study.